Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-06-07
1997-05-20
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
A61K 3800
Patent
active
056312342
ABSTRACT:
The present invention provides a preventive or therapeutic agent for tissue injury caused by active oxygens and free radicals, having for its effective component .gamma.-L-glutamyl-L-cysteine ester derivative indicated in the following general formula: ##STR1## wherein, R is a straight chain, branched or cyclical hydrocarbon group having 1-10 carbon atoms, or a straight chain or branched hydrocarbon group having 1-5 carbons substituted with an aromatic group, or its oxidized dimer.
This compound has the effect of elevating glutathione levels in tissue and biochemically substitute for glutathione thereby performing preventive or therapeutic effects against ischemia-reperfusion tissue injury in the heart, liver and other organs, arrhythmia, as well as lung injury caused by active oxygens and free radicals.
REFERENCES:
patent: 4927808 (1990-05-01), Kitahara
Kobayashi et al., "The Effects of .gamma.-Glutamylcysteine Ethyl Ester, a Prodrug of Glutathione, on Ischemia-Reperfusion-Induced Liver, Injury in Rats," Transplantation, vol. 54, No. 3, pp. 414-418, Sep. 1992.
Ikuta et al., "Implication of Oxygen Radicals on Airway Hyperresponsiveness After Ovalbumin Challenge in Guinea Pigs," American Review of Respiratory Disease, vol. 145, No. 3, pp. 561-65, Mar. 1992.
Nishinaka et al., "The Cardioprotective Effect of .gamma.-Glutamylcysteine Ethyl Ester During Coronary Reperfusion in Canine Hearts", British Journal of Pharmacology, vol. 104, No. 4, pp. 805-810, Dec. 1991.
Ohtsu et al., "Anticataractogenic Property of .gamma.-Glutamylcysteine Ethyl Ester in an Animal Model of Cataract," Ophthalmic Research, vol. 23, No. 1, pp. 51-58, Jan. 1991.
Singh et al., "Relation Between Myocardial Glutathione Content and Extent of Ischemia-Reperfusion Injury," Circulation, vol. 80, No. 6, pp. 1795-1804, 1989.
Blaustein et al., "Protective Effects of Glutathione on Ventricular Compliance and Coronary Resistance During Ischemia/Reperfusion," FASEB, vol. 3, No. 3, p. A627, Mar. 1989.
Stein et al., "Oxygen Free Radicals and Glutathione in Hepatic Ischemia/Reperfusion Injury," Journal of Surgical Research, vol. 50, No. 4, pp. 398-402, Apr. 1991.
Marubayashi et al., "Changes in the Levels of Endogenous Coenzyme Q Homologs, .alpha.-Tocopherol, and Glutathione in Rat Liver After Hepatic Ischemia and Reperfusion, and the Effect of Pretreatment with Coenzyme Q.sub.10," Biochimica et Biophysica Acta, vol. 797, No. 1, pp. 1-9, Jan. 24, 1984.
Woodward et al., "Effect of Some Free Radical Scavengers on Reperfusion Induced Arrhythmias in the Isolated Rat Heart," J. Mol. Cell Cardiol., vol. 17, No. 5, pp. 485-493, 1985.
Lackson et al., "Effects of Hypoxia (Ischemia) and Re-Oxygenation (Reperfusion) on Lung Glutathione System," American Review of Respiratory Disease, vol. 139, No. 4, p. A39, Apr. 1989.
Pschyrembel, 256 ed., 1990, p. 1142 "Nekrose".
Flohe et al., "The Identity of Glutathione Peroxidase from Erythrocytes and Liver (Contraction Factor I) of the Rat", Journal of Clinical Chemistry and Clinical Biochemistry, Mar. 1970.
YiMin et al., "Various Diseases Caused by Free Radical," Contemporary Medicine Journal, vol. 18, Period 5, pp. 54-62, Extract, Republic of China, May 15, 1989.
Journal of Neurochemistry, vol. 34, pp. 477-486, 1980.
Circulation, vol. 81, pp. 201-211, 1990.
Lung, vol. 169, pp. 123-138, 1991.
Current Surgery, Jan./Feb. 1988 Issue.
Marubayashi et al., Biochimica et Biophysica Acta, vol. 797, No. 1, pp. 1-9, 1984.
Fujii Katsuhiko
Kitahara Shigehisa
Ozawa Takayuki
Sugiyama Satoru
Jordan Kimberly
Teijin Limited
LandOfFree
Method for treating ischemia-reperfusion tissue injury does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating ischemia-reperfusion tissue injury, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating ischemia-reperfusion tissue injury will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1723932